SEC Comment Letter 0000000000-23-011173 to ALTERITY THERAPEUTICS LTD (ATHE, PRNAF) (CIK 0001131343) (ATHE)
ALTERITY THERAPEUTICS LTD (ATHE, PRNAF) (CIK 0001131343)
Date: Oct. 12, 2023 · CIK: 0001131343 · Accession: 0000000000-23-011173
AI Filing Summary & Sentiment
File numbers found in text: 333-274816
Letter
United States securities and exchange commission logo October 12, 2023 David Stamler Chief Executive Officer ALTERITY THERAPEUTICS LTD Level 14, 350 Collins Street Melbourne, Victoria 3000, Australia Re:ALTERITY THERAPEUTICS LTD Registration Statement on Form F-3 Filed October 2, 2023 File No. 333-274816 Dear David Stamler: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Cindy Polynice at 202-551-8707 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: David Rodda, Esq.
Show Raw Text
United States securities and exchange commission logo
October 12, 2023
David Stamler
Chief Executive Officer
ALTERITY THERAPEUTICS LTD
Level 14, 350 Collins Street
Melbourne, Victoria 3000, Australia
Re:ALTERITY THERAPEUTICS LTD
Registration Statement on Form F-3
Filed October 2, 2023
File No. 333-274816
Dear David Stamler:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Cindy Polynice at 202-551-8707 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: David Rodda, Esq.